Literature DB >> 20138830

Chronic hepatitis C viral infection reduces NK cell frequency and suppresses cytokine secretion: Reversion by anti-viral treatment.

Omar Dessouki1, Yasuyuki Kamiya, Hiroyasu Nagahama, Motohiko Tanaka, Shinya Suzu, Yutaka Sasaki, Seiji Okada.   

Abstract

Impaired activity of NK (natural killer) cells has been proposed as a mechanism contributing to viral persistence and chronic infection in hepatitis C (HCV) infection. We aimed to assess the impact of HCV infection on NK cells regarding frequency, subset distribution, and cytotoxic and cytokine secretion functions, as well as IFN-alpha and ribavirin therapeutic effects on NK cells. Significant reduction of total NK frequency and the CD56(dim)16(+) subset was observed in chronic HCV patients. IFN-gamma expression upon stimulation with K562 was severely suppressed but cytotoxicity measured by CD107a expression was maintained. These adverse effects were reversed after treatment with pegylated IFN-alpha and ribavirin; however, these skewed functions were not recovered in treatment-resistant patients. Thus, HCV chronic infection severely affects NK functions, except for cytotoxicity. Altered NK cell frequency and cytokine secretion by HCV infection may contribute to impaired cellular immune response and virus persistence. 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20138830     DOI: 10.1016/j.bbrc.2010.02.008

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  36 in total

1.  Successful Interferon-Free Therapy of Chronic Hepatitis C Virus Infection Normalizes Natural Killer Cell Function.

Authors:  Elisavet Serti; Xenia Chepa-Lotrea; Yun Ju Kim; Meghan Keane; Nancy Fryzek; T Jake Liang; Marc Ghany; Barbara Rehermann
Journal:  Gastroenterology       Date:  2015-03-06       Impact factor: 22.682

Review 2.  NK cells and their ability to modulate T cells during virus infections.

Authors:  Kevin D Cook; Stephen N Waggoner; Jason K Whitmire
Journal:  Crit Rev Immunol       Date:  2014       Impact factor: 2.214

3.  Early changes in natural killer cell function indicate virologic response to interferon therapy for hepatitis C.

Authors:  Golo Ahlenstiel; Birgit Edlich; Leah J Hogdal; Yaron Rotman; Mazen Noureddin; Jordan J Feld; Lauren E Holz; Rachel H Titerence; T Jake Liang; Barbara Rehermann
Journal:  Gastroenterology       Date:  2011-07-07       Impact factor: 22.682

Review 4.  NK cells, innate immunity and hepatitis C infection after liver transplantation.

Authors:  Anoma Nellore; Jay A Fishman
Journal:  Clin Infect Dis       Date:  2011-02-01       Impact factor: 9.079

5.  Long-term effect on natural killer cells by interferon-α therapy on the outcomes of HCV infection.

Authors:  Xiaoli Hu; Yanfang Jiang; Xiurong Li; Yanhang Gao; Xiaoli Guo; Xiumei Chi; Hongqing Yan; Junyan Feng; Jin Zhong; Bing Sun; Xue Shao; Weihua Xiao; Yu Pan; Junqi Niu
Journal:  J Interferon Cytokine Res       Date:  2013-12-24       Impact factor: 2.607

6.  KLRG1 negatively regulates natural killer cell functions through the Akt pathway in individuals with chronic hepatitis C virus infection.

Authors:  Jia M Wang; Yong Q Cheng; Lei Shi; Ruo S Ying; Xiao Y Wu; Guang Y Li; Jonathan P Moorman; Zhi Q Yao
Journal:  J Virol       Date:  2013-08-21       Impact factor: 5.103

7.  IFN-γ production by human natural killer cells in response to HCV-infected hepatoma cells is dependent on accessory cells.

Authors:  Shuye Zhang; Banishree Saha; Karen Kodys; Gyongyi Szabo
Journal:  J Hepatol       Date:  2013-05-07       Impact factor: 25.083

Review 8.  Direct effects of hepatitis C virus on the lymphoid cells.

Authors:  Yasuteru Kondo; Tooru Shimosegawa
Journal:  World J Gastroenterol       Date:  2013-11-28       Impact factor: 5.742

9.  Natural cytotoxicity receptor-dependent natural killer cytolytic activity directed at hepatitis C Virus (HCV) is associated with liver inflammation, African American race, IL28B genotype, and response to pegylated interferon/ribavirin therapy in chronic HCV infection.

Authors:  Qinglai Meng; M R Sandhya Rani; Julia M Sugalski; Chelsey J Judge; Sarah Phat; Benigno Rodriguez; Ronald E Blanton; Donald D Anthony
Journal:  J Infect Dis       Date:  2013-12-02       Impact factor: 5.226

Review 10.  Natural killer cells: multifaceted players with key roles in hepatitis C immunity.

Authors:  Lucy Golden-Mason; Hugo R Rosen
Journal:  Immunol Rev       Date:  2013-09       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.